Leptospirosis Clinical Trial
Official title:
Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia
The objective of the study is to estimate the incidence of Jarisch-Herxheimer Reactions (JHR) during antibiotic treatment of human leptospirosis cases in New Caledonia. Participants are patients managed in one of the 5 centres participating in the study, in whom a clinical doctor suspected leptospirosis. The average number of leptospirosis cases in New Caledonia is 89 per year. Given the proportion of positive diagnostic tests (approximately 10%) 900 inclusions are planned for this study. Patients are included at the time of the consultation during which leptospirosis is suspected, before the initiation of their antibiotic therapy and independently of the clinical form they presented. Data (socio-demographic and health) and blood samples will be collected at 3 points in the study: at baseline, three hours and six hours after antibiotic treatment. This study will allow better management of patients with leptospirosis.
The objective of the study is to estimate the incidence of Jarisch-Herxheimer Reactions (JHR) during antibiotic treatment of human leptospirosis cases in New Caledonia. Secondary objectives of the study are to describe the JHR during leptospirosis (describe clinical, haemodynamic and cytokine response parameters), to describe the effects of the progressive introduction of antibiotic (ATB) for the treatment of leptospirosis and to harmonise management practices for patients with leptospirosis in NC. Participants are patients managed in one of the 5 centres participating in the study, in whom a clinical doctor suspected leptospirosis. The average number of leptospirosis cases in New Caledonia (NC) is 89 per year. Given the proportion of positive diagnostic tests (approximately 10%) 900 inclusions are planned for this study. Patients are included at the time of the consultation during which leptospirosis is suspected, before the initiation of their antibiotic therapy and independently of the clinical form they presented. Blood samples will be collected at 3 points in the study: at baseline, three hours and six hours after antibiotic treatment. Data will be collected at 4 points in the study: at baseline, three hours, six hours after antibiotic treatment and one day after treatment introduction (last point by phone call). The data obtained will allow us to describe for the first time, in a prospective study, the JHR associated with leptospirosis in a significant number of patients. The data obtained will also help to describe the impact of a therapeutic strategy on the evolution of the disease, which has not yet been evaluated. This study also aims to help harmonise the management of patients with leptospirosis in NC. This study will allow better management of patients with leptospirosis. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02898519 -
Immune Response After Leptospirosis Infection
|
N/A | |
Recruiting |
NCT05425524 -
Leptospirosis Care Bundle Study
|
N/A | |
Completed |
NCT03912506 -
Severe Leptospirosis in Non-tropical Areas
|
||
Recruiting |
NCT04288674 -
Leptospirosis Registry - LeptoScope
|
||
Recruiting |
NCT05300425 -
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
|
||
Completed |
NCT01080989 -
The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands
|
N/A | |
Recruiting |
NCT05436756 -
Chronic Post-leptospirosis Manifestations in Reunion
|
N/A | |
Terminated |
NCT00592566 -
Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT04034550 -
Cohort of Hospitalized Patients Suspected of Leptospirosis
|
N/A | |
Completed |
NCT05413720 -
Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO
|
N/A | |
Completed |
NCT01766830 -
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
|
N/A | |
Recruiting |
NCT02000635 -
Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique
|
||
Active, not recruiting |
NCT01607047 -
French West Indies Leptospirosis Study
|
||
Completed |
NCT03497572 -
Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine
|